Olema Pharmaceuticals (OLMA) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about OLMA filings

Are insiders buying or selling Olema Pharmaceuticals Inc (OLMA) stock?

Neither. Olema Pharmaceuticals Inc (OLMA) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded OLMA recently?

None. No member of Congress disclosed a OLMA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this OLMA smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

CHHarmonInsider, filed Jul 27Sold$291K

Smart money on OLMA

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Cyrus Harmon, sold $291K, open market, filed Jul 27
Lean short · thin1 sale · $291K
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about OLMA filings

Are insiders buying or selling Olema Pharmaceuticals Inc (OLMA) stock?

Neither. Olema Pharmaceuticals Inc (OLMA) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded OLMA recently?

None. No member of Congress disclosed a OLMA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this OLMA smart-money data?

Insiders

What insiders are doing

1 trade · 6 mo

Sold$291K

Sells (1)

HC
Harmon Cyrus
Dir · Jul 27
$291K
sold
Signals like this: n=8127, 50% finished lower at D15, median -0.1% vs SPY +0.6%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in 15.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.73-15.16% miss

-$0.63 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

-$0.66

-$0.73 to -$0.52

Last 30 days

1up7down

Analysts cutting estimates

Estimate drift

+0.01

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$0.73est. -$0.63	-15.16%miss	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2026Reported Aug 10, 2026	-$0.61est. -$0.53	-15.09%miss	Not on file	Not on file
Mar 31, 2026Reported May 12, 2026	-$0.52est. -$0.54	+3.51%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 16, 2026	-$0.50est. -$0.53	+5.10%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 10, 2025	-$0.49est. -$0.45	-8.49%miss	Not on file	Not on file
Jun 30, 2025Reported Aug 11, 2025	-$0.51est. -$0.44	-15.91%miss	Not on file	Not on file
Mar 31, 2025Reported May 13, 2025	-$0.36est. -$0.46	+21.74%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 18, 2025	-$0.51est. $0.17	-$0.68miss	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $7.88
High: $8.02
Low: $7.45
Prev close: $8.04
52-wk high: $36.26
52-wk low: $6.24
Mkt cap: $704.4M
ROE: -69.8%
Beta: 2.02
P/B: 1.7x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $704M

Valuation

P/B1.72

Quality

Operating margin0.0%
ROE-69.8%
ROA-39.8%

Growth

Beta2.02

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

61balanced

20D volatility

92%annualized

52-week range

$7.52

$6.24$36.26

20D support

$6.24recent floor

20D resistance

$8.26recent ceiling

Returns

5D +11.2%20D +9.5%60D -33.5%

Price vs moving averages

SMA20 +5.1%SMA50 -8.8%SMA200 -42.9%

Volume pace

1.07xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 10, 2026

-$0.73est. -$0.63

-15.16%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2026Aug 10, 2026

-$0.61est. -$0.53

-15.09%

Not on file

Mar 31, 2026May 12, 2026

-$0.52est. -$0.54

+3.51%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Mar 16, 2026

-$0.50est. -$0.53

+5.10%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 10, 2025

-$0.49est. -$0.45

-8.49%

Not on file

Jun 30, 2025Aug 11, 2025

-$0.51est. -$0.44

-15.91%

Not on file

Mar 31, 2025May 13, 2025

-$0.36est. -$0.46

+21.74%

Not on file

Dec 31, 2024Mar 18, 2025

-$0.51est. $0.17

-$0.68

Not on file

Olema Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about OLMA filings

Smart money on OLMA

Questions about OLMA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 15.2% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Olema Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about OLMA filings

Smart money on OLMA

Questions about OLMA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 15.2% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Olema Pharmaceuticals Inc

Overview

Questions about OLMA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Olema Pharmaceuticals Inc

Overview

Questions about OLMA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.